HHS seems poised to exert control over USPSTF Ransohoff: The task force is the pinnacle of evidence-based medicine

HHS halts nearly $500M in mRNA-related vaccine contracts

The Department of Health and Human Services has announced the start of a reduction in its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority.

August 08, 2025

Vol.51 No.31

By Claire Marie Porter

Guest Editorial

USPSTF doesn’t lean right or left—it’s about data, not politics

Multiple components of the healthcare and public health systems are currently under scrutiny. One of them is reportedly the U.S. Preventive Services Task Force (USPSTF: “Task Force”), established in 1984 and managed by the Agency for Healthcare Research and Quality. It was created to maintain an ongoing evaluation of disease prevention and screening interventions that...

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Do multi-cancer detection tests provide a net benefit? NCI aims to answer this question, beginning with the Vanguard feasibility trial which recently started accruing patients.

July 30, 2025

Vol.51 No.29

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya

In a move that will have direct impact on approval of cancer drugs, George Francis Tidmarsh, an oncologist and a longtime pharmaceutical executive, was named director of the FDA Center for Drug Evaluation and Research.

July 25, 2025

Vol.51 No.29

By Claire Marie Porter

Cancer Policy

NIH says it’s moving away from animal-based models

NIH has announced that it will no longer be issuing Notices of Funding Opportunities exclusively supporting animal models.

July 18, 2025

Vol.51 No.28

By Claire Marie Porter

Cancer Policy

CMS proposes policy to move away from hospital-based care

The Centers for Medicare & Medicaid Services issued a proposed rule that would update Medicare payment policies and rates for hospital outpatient departments and ambulatory surgical centers, or ASCs, for calendar year 2026.

July 18, 2025

Vol.51 No.28

By Claire Marie Porter

HHS seems poised to exert control over USPSTF

Ransohoff: The task force is the pinnacle of evidence-based medicine

YOU MAY BE INTERESTED IN

HHS halts nearly $500M in mRNA-related vaccine contracts

USPSTF doesn’t lean right or left—it’s about data, not politics

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya

NIH says it’s moving away from animal-based models

CMS proposes policy to move away from hospital-based care

Renew today!

Subscriber content

Never miss an issue!

Login

HHS seems poised to exert control over USPSTF

Ransohoff: The task force is the pinnacle of evidence-based medicine

YOU MAY BE INTERESTED IN

HHS halts nearly $500M in mRNA-related vaccine contracts

USPSTF doesn’t lean right or left—it’s about data, not politics

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER directorHis appointment came out of “proximity” to Makary and Bhattacharya

NIH says it’s moving away from animal-based models

CMS proposes policy to move away from hospital-based care

Never miss an issue!

Login

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya